Influenza research

First Cancer Vaccines could be widely Available before 2030

Vaccines to fight cancer will be widely available before 2030, say husband and wife Prof. Ugur Şahin and Prof. Özlem Tureçi, creators of one of the most successful vaccines against COVID-19, writes in the New York Times.

Lessons learned from the pandemic will accelerate cancer treatments based on mRNA technology, they say.

Vaccine Nationalism - Governments Pay to Bring Production Home

The COVID pandemic is an unprecedented challenge to inoculate billions around the world. While the drugs are badly needed in the near term, some countries already are developing piecemeal plans reflecting the lack of any coherent global strategy to cover vaccination in a pandemic, which the world needs.

Bulgarian Immunologist: People with Autoimmune Diseases and Overweight Should Better Have Vaccine

It turned out that Covid-19 vaccines manufacturers cannot not cope with the flood of deliveries, they even warned that they might be late. But each country should get vaccines population-proportional. Israel pays USD 30 per dose, so they arrive there first. Not only Israel, but many Middle Eastern countries have purchased vaccines as a priority, at a higher cost.

Beijing vaccinates thousands in COVID-19 jab drive

Thousands of people were lining up in Beijing to receive a COVID-19 vaccine as China races to innoculate millions before the Chinese New Year mass travel season in February.

More than 73,000 people in the Chinese capital have received the first dose of the vaccine over the last couple of days, state media reported on Jan. 3, including community workers and bus drivers.

Rich Countries Overstocking Vaccines, Poor Ones Lagging Far Behind

There are fears that poorer countries could be left behind as richer nations "hoard" more doses of coronavirus vaccine than they need.

Wealthy countries have amassed a big enough stock of vaccine doses to immunize their people nearly three times over by the end of next year, assuming the vaccines in clinical trials are all approved for use.

Pages